Related Experiment Video
Updated: Aug 12, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Future directions for vaccine-related onchocerciasis research
1Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0425, USA. tnutman@niaid.nih.gov
Abstract:
Although the general perception has been that Onchocerca volvulus infection is well on its way towards extinction, it is becoming increasingly clear that without an additional therapeutic or preventative modality (separate from ivermectin distribution or vector control), elimination of onchocercal infection will remain an unfulfilled goal. Vaccination aimed at preventing infection (directed toward infective-stage or adult worms), transmission and/or pathology (directed toward skin microfilariae) could provide the necessary 'final punch' to knockout human infection with O. volvulus altogether. Thus, efforts toward the development of a useful vaccine need to be redoubled rather than shelved, and, to this end, major gaps in our knowledge need to be filled.
Insights
Onchocerca volvulus infection elimination requires new strategies beyond current ivermectin and vector control methods. Developing a vaccine against this parasitic disease is crucial for its complete eradication.
Area of Science:
- Medical Parasitology
- Tropical Diseases
- Vaccine Development
Background:
- Onchocerca volvulus infection, or river blindness, is a major public health concern in endemic regions.
- Current control strategies, including ivermectin distribution and vector control, have reduced disease burden but not achieved elimination.
- A significant gap exists in therapeutic and preventative modalities beyond existing interventions.
Purpose of the Study:
- To highlight the limitations of current Onchocerca volvulus control programs.
- To emphasize the critical need for a complementary vaccine strategy for disease elimination.
- To advocate for intensified research and development of an Onchocerca volvulus vaccine.
Main Methods:
- Review of current Onchocerca volvulus control strategies and their limitations.
- Analysis of potential vaccine targets, including infective-stage/adult worms and skin microfilariae.
- Identification of knowledge gaps hindering vaccine development.
Main Results:
- Existing control measures are insufficient for complete Onchocerca volvulus elimination.
- Vaccination offers a potential 'final punch' to eradicate the infection.
- Significant knowledge gaps impede the development of an effective vaccine.
Conclusions:
- Onchocerca volvulus elimination is unlikely without novel interventions.
- Vaccine development targeting different parasite stages is essential.
- Renewed efforts and research are needed to fill knowledge gaps and develop a viable vaccine.
